The Importance of HbA1c Reduction in Adult Type 2 Diabetes
July 15 @ 7:00 pm – 8:45 pm
Join us for this promotional webinar covering an overview of the latest updates in diabetes management, including the new NG28 clinical categories (Feb 2026), updated guidance, and revised HbA1c targets. The session will also explore the importance of early HbA1c reduction in lowering long-term risk, alongside the evolving role of early SGLT2 therapy in improving patient outcomes.
Talking points include:
- Complications of Diabetes
- New Clinical Categories in NG28 Feb 2026 Updated Guidance
- Key Features of the New Guidance
- HbA1c Targets
- Importance of HbA1c Reduction to Reduce Risk
- The Importance of Early SGLT2 initiation
Speakers:
Prof Raj Thakkar – President and CKD Lead, Primary care Cardiovascular Society;GP and Honorary Visiting Professor, Cardiff University
Meredith Donaldson – PA, MSc, PhD candidate
Supported and funded by A. Menarini Farmaceutica Internazionale SRL including honoraria in accordance with the ABPI code of practice.
